NSF focuses on regulatory affairs for QA and QPs with March workshops

One of the primary roles for QPs (Qualified Persons and other quality professionals) is to make sure that the products released for sale are in compliance with the requirements of the marketing authorisation (MA) for that product.

It therefore follows that QPs need a solid understanding of how MAs are constructed and applied for initially and how they are kept up to date by the submission of variations. The following two workshops are designed for QPs and QA to ensure that they have a firm understanding of these two areas.

The workshop on Marketing Authorisations will cover:

  • Regulatory agency expectations on the data that should be included in an e-CTD
  • What can (and often) does go wrong when too much/the wrong information is registered
  • The role of the QP/QA in managing what is registered
  • New/emerging CMC requirements – what’s coming up?
The workshop on Variations will cover:

  • Regulatory agency expectations on the data that should be included in variation
  • The categorisation of post-approval changes; e.g. 1A, 1B, Type 2 in EU and CBE0, CBE30 or prior approval in USA
  • The need for the QP/QA to be kept informed regarding post-approval changes via an effective change control process
  • New/emerging expectations arising from ICH Q12

Places on these workshops are limited to allow for maximum discussion and interaction. Follow the below links for more information and to book a place:

Featured Companies

NSF Health Sciences (more information, website)